We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Why Did Asarian Energy (TSX:ARN) Fall 10% on Below-Normal Volume?

Asarian Energy (TSX:ARN) is a uranium developer whose main asset is the Norasa project in the Erongo region of Namibia, which combines the Valencia and Namibplaas deposits. On Tuesday, October 20, 2026, the shares fell 10.00% to CAD 0.405, from an implied prior close …

Vinay Lochav | 21 October 2026

Can Komzifti Carry Kura Oncology (NASDAQ:KURA) Past a USD 0.77 Loss?

Kura Oncology (NASDAQ:KURA) is a biotechnology company whose lead product, Komzifti (ziftomenib), treats a genetically defined form of acute myeloid leukaemia, a blood cancer. Shares traded near USD 10.13 early on Wednesday, October 21, 2026, against USD 9.94 at 2:52 p.m. ET on Tuesday, …

Vinay Lochav | 21 October 2026

Why Did Telesat (TSX:TSAT) Fall 9.82% as Lenders Push a Rescue Deal?

Telesat (TSX:TSAT) is a Canadian satellite operator building Lightspeed, a low Earth orbit broadband constellation, and its shares fell 9.82% to CAD 57.47 on Tuesday, October 20, 2026. Volume was 80,340 shares, 1.73 times normal, while the Nasdaq-listed shares fell about 5.9%. The decline …

Vinay Lochav | 21 October 2026

Why Does Ellington Financial (NYSE:EFC) Yield 13.5% Near Its Low?

Ellington Financial (NYSE:EFC) is a specialty finance company that invests in residential and commercial mortgage loans, consumer loans and mortgage-backed securities, and it is managed by an affiliate of Ellington Management Group. The shares closed at USD 11.65 on Friday, October 16, 2026, down …

Vinay Lochav | 21 October 2026

Why Did Edge Copper (TSX:EDCU) Fall 9.5% With No Company News?

Edge Copper (TSX:EDCU) is developing the Zonia project in central Arizona, an oxide copper deposit suited to heap leaching, in which a weak acid dissolves copper from stacked ore before solvent extraction and electrowinning produce cathode. On Tuesday, October 20, 2026, the shares fell …

Vinay Lochav | 21 October 2026

Can Evolent Health (NYSE:EVH) Turn 46.9% Revenue Growth Into Profit?

Evolent Health (NYSE:EVH) manages specialty care, chiefly oncology, cardiology and musculoskeletal services, for health plans, often taking financial risk on the cost of that care. Shares rose about 8.04% to USD 4.84 by 1:05 p.m. ET on Tuesday, October 20, 2026, from USD 4.48, …

Vinay Lochav | 21 October 2026

Why Did DRI Healthcare Trust (TSX:DHT.U) Fall 9.15% on 519 Units?

DRI Healthcare Trust (TSX:DHT.U) owns royalties on patent-protected pharmaceutical products and trades on the TSX in two lines: DHT.UN in CAD and DHT.U in US dollars. The US dollar units fell 9.15% to USD 11.62 on Tuesday, October 20, 2026, on 519 units, about …

Vinay Lochav | 21 October 2026

Why Did Forte Minerals (CSE:CUAU) Fall 8.78% on 3,700 Shares Traded?

Forte Minerals (CSE:CUAU) is a copper and gold explorer focused on Peru, and its shares fell 8.78% to CAD 1.35 in the session. Market data show about 3,700 shares traded, which at the closing price is a turnover of roughly CAD 5,000. Relative volume …

Vinay Lochav | 21 October 2026

Can a 76% Slower Decline Win Capricor (NASDAQ:CAPR) FDA Approval?

Capricor Therapeutics (NASDAQ:CAPR) develops deramiocel, an investigational cell therapy for Duchenne muscular dystrophy, an inherited disease that progressively destroys muscle in boys. The company submitted a major amendment to its Biologics License Application, the filing that seeks FDA approval, including the open-label extension data, …

Vinay Lochav | 21 October 2026

What Does Theravance Add to Zymeworks (NASDAQ:ZYME) at USD 27.25?

Zymeworks (NASDAQ:ZYME) is a biotechnology company that discovered Ziihera (zanidatamab), a HER2-targeted bispecific antibody, meaning one that binds two targets, commercialised by Jazz Pharmaceuticals (NASDAQ:JAZZ) and BeOne Medicines (NASDAQ:ONC). It completed the acquisition of Theravance Biopharma on Wednesday, September 23, 2026, adding YUPELRI (revefenacin) …

Vinay Lochav | 21 October 2026
Support

Hi! How can we help you today?

Loading…